REPR 2018 Shareholders Meeting

Operating Highlights Record net revenues – up 12.4% Gross margin increased by 230 bps Higher income and Adjusted EBITDA Strong balance sheet with no debt and simple capital structure Refreshed and strengthened management team Added significant talent to the Board February 2019: strategic plan launched to become the preferred drug delivery partner for specific infusion … Continued

February 2019 Investor Presentation

Presentation Highlights:  Refreshed, strengthened management team Established strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets Net Revenue increased 12.4% to $17.4 million from $15.4 million Adjusted EBITDA* expanded to $2.7 million, up 73.9% from $1.6 million in 2017 This presentation contains forward looking statements that involve risks … Continued

Fourth Quarter 2018 Results Conference Call

Conference Call Highlights:  Refreshed, strengthened management team Established strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets Net Revenue increased 12.4% to $17.4 million from $15.4 million Adjusted EBITDA* expanded to $2.7 million, up 73.9% from $1.6 million in 2017 This presentation contains forward-looking statements that involve risks … Continued

REPR November Investor Presentation – 11.13.18

Presentation Highlights: Net Sales increased 18.1% to $4.5 million Gross margin improved to 63.6% compared to 61.8% Net income grew to $386,553; 8.5% of net sales Don Pettigrew was appointed to President and Chief Commercial Officer on Spetmber 4th, 2018   This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited … Continued

Liolis Gateway September 2018 Presentation

Liolis Gateway Presentation Highlights: Global leader in mechanical infusion systems Flagship FREEDOM60® system enables self-administered home infusion Part of the solution to today’s healthcare challenges New senior leadership focused on growth & value creation This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of … Continued